On January 17, 2023, Zhejiang Ausun Pharmaceutical Co., Ltd. closed the transaction. The company has issued 21,754,288 shares at an issue price of CNY 22.29 per share for gross proceeds of CNY 484,903,079.52. The company has paid issuance expenses of CNY 10,969,297.60, the net amount of funds raised is CNY 473,933,781.92, of which CNY 21,754,288.00 is included in the share capital, and CNY 452,179,493.92 is included in the capital reserve-share capital premium.

The transaction included participation from Shanghai Panjing Investment Management Center (Limited Partnership) for 672,947 shares, for proceeds of CNY 14,999,988.63, Shanghai Taizhou Financial Holding Asset Management Co., Ltd. for 4,037,685 shares, for proceeds of CNY 89,999,998.65, Gongqingcheng Shengheng Investment Management Co., Ltd. for 2,889,187 shares, for proceeds of CNY 64,399,978.23, and other investors.